HENNEMAN JOHN B III bought ANIK
May 1, 2026 · Form 4 insider transaction
HENNEMAN JOHN B III bought 5,000 shares of Anika Therapeutics, Inc. at $14.66 per share, a transaction worth $73.3K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
5,000
Price
$14.66
Total value
$73.3K
InsiderHENNEMAN JOHN B III
RoleDirector
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateMay 1, 2026
Filing dateMay 4, 2026
Shares owned after54,871
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $14.595 to $14.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.